CannIntelligence CBN and CBG database

So far, the attention of the cannabis industry and regulatory activity on cannabinoids have tended to focus on CBD and THC. Nevertheless, other cannabinoids are now emerging as popular alternatives for consumers.

However, only a few countries have taken steps to regulate these lesser-known cannabinoids, which has created a patchwork of regulation for them.

This tracker sets out to guide you through the legal status and classification of two of the most popular cannabinoids, after CBD and THC, in 50 selected countries:

• Cannabinol, or CBN, a mildly psychoactive cannabinoid
• Cannabigerol, or CBG, a non-psychoactive cannabinoid

It covers: Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Russia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, Ukraine, UK, Uruguay, USA.

Platinum subscribers to CannIntelligence have access to regular updates of this product through their subscriptions.

 

*You will receive the most up-to-date version of the purchased database directly to your inbox within 24 hours.

*If you choose to subscribe to CBD-Intel within 30 days of purchasing one of our premium data bundles, we will credit the price of the purchased bundle to your first year’s subscription.